Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Oncotelic Therapeutics's operating income for the twelve months ending Jun 30, 2025 was -$3.48M. For fiscal 2025 it was -$3.19M. The highest annual figure on record is -$712.74K in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.19M | – |
| FY2024 | Dec 31, 2024 | -$3.58M | – |
| FY2023 | Dec 31, 2023 | -$6.65M | – |
| FY2022 | Dec 31, 2022 | -$9.72M | – |
| FY2021 | Dec 31, 2021 | -$9.13M | – |
| FY2020 | Dec 31, 2020 | -$7.58M | – |
| FY2019 | Dec 31, 2019 | -$4.31M | – |
| FY2018 | Dec 31, 2018 | -$712.74K | – |
| FY2017 | Dec 31, 2017 | -$13.84M | – |
| FY2016 | Dec 31, 2016 | -$13.76M | – |
| FY2015 | Dec 31, 2015 | -$13.68M | – |
| FY2014 | Dec 31, 2014 | -$12.65M | – |
| FY2013 | Dec 31, 2013 | -$8.28M | – |
| FY2012 | Dec 31, 2012 | -$8.07M | – |
| FY2011 | Dec 31, 2011 | -$11.89M | – |
| FY2010 | Dec 31, 2010 | -$18.51M | – |
| FY2009 | Dec 31, 2009 | -$31.16M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$843.57K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$65.97K | – |
| Q1 FY2025 | Mar 31, 2025 | -$101.10K | – |
| Q4 FY2024 | Dec 31, 2024 | -$31.45K | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.28M | -22760.3% |
| Q2 FY2024 | Jun 30, 2024 | -$96.58K | – |
| Q1 FY2024 | Mar 31, 2024 | -$167.22K | – |
| Q4 FY2023 | Dec 31, 2023 | -$113.46K | – |
| Q3 FY2023 | Sep 30, 2023 | $14.48K | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.32M | – |
| Q1 FY2023 | Mar 31, 2023 | -$264.12K | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$595.44K | – |
| Q2 FY2022 | Jun 30, 2022 | -$256.32K | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.81M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.76M | -27298.1% |
| Q1 FY2021 | Mar 31, 2021 | -$2.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.33M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.62M | – |
| Q2 FY2020 | Jun 30, 2020 | $13.84K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.65M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$930.71K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.16M | – |
| Q1 FY2019 | Mar 31, 2019 | -$976.06K | – |
| Q4 FY2018 | Dec 31, 2018 | -$154.60K | – |
| Q3 FY2018 | Sep 30, 2018 | -$214.03K | – |
| Q2 FY2018 | Jun 30, 2018 | -$153.31K | – |
| Q1 FY2018 | Mar 31, 2018 | -$795.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.44M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.54M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.90M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.97M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.26M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.67M | – |
See a number that looks wrong?